EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo.
Clin Transl Immunology. 2020 May 3;9(5):e01135. doi: 10.1002/cti2.1135. eCollection 2020 May.
Clin Transl Immunology. 2020.
PMID: 32373345
Free PMC article.